Evaluation of oncological outcomes of robotic partial nephrectomy according to the type of hilar control approach (On-clamp vs Off-clamp), a multicentric study of the French network of research on kidney cancer-UROCCR 58-NCT03293563.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 09 10 2020
accepted: 07 12 2020
pubmed: 20 2 2021
medline: 25 2 2023
entrez: 19 2 2021
Statut: ppublish

Résumé

To compare off-clamp vs on-clamp robotic partial nephrectomy (RPN) for renal cell carcinoma (RCC) in terms of oncological outcomes, and to assess the impact of surgical experience (SE). We extracted data of a contemporary cohort of 1359 patients from the prospectively maintained database of the French national network of research on kidney cancer (UROCCR). The primary objective was to assess the positive surgical margin (PSM) rate. We also evaluated the oncological outcomes regardless of the surgical experience (SE) by dividing patients into three groups of SE as a secondary endpoints. SE was defined by the caseload of RPN per surgeon per year. For the continuous variables, we used Mann-Whitney and Student tests. We assessed survival analysis according to hilar control approach by Kaplan-Meier curves with log rank tests. A logistic regression multivariate analysis was used to evaluate the independent factors of PSM. Outcomes of 224 off-clamp RPN for RCC were compared to 1135 on-clamp RPN. PSM rate was not statistically different, with 5.6% in the off-clamp group, and 11% in the on-clamp group (p = 0.1). When assessing survival analysis for overall survival (OS), local recurrence-free survival (LR), and metastasis-free survival (MFS) according to hilar clamping approach, there were no statistically significant differences between the two groups with p value log rank = 0.2, 0.8, 0.1, respectively. In multivariate analysis assessing SE, hilar control approach, hospital volume (HV), RENAL score, gender, Age, ECOG, EBL, BMI, and indication of NSS, age at surgery was associated with PSM (odds ratio [OR] 1.03 (95% CI 1.00-1.04), 0.02), whereas SE, HV, and type of hilar control approach were not predictive factors of PSM. Hilar control approach seems to have no impact on PSM of RPN for RCC. Our findings were consistent with randomized trials.

Identifiants

pubmed: 33606044
doi: 10.1007/s00345-020-03558-5
pii: 10.1007/s00345-020-03558-5
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

287-294

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Références

Ljungberg B et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924. https://doi.org/10.1016/j.eururo.2015.01.005
doi: 10.1016/j.eururo.2015.01.005 pubmed: 25616710
Gill IS, Aron M, Gervais DA, Jewett MAS (2010) Small renal mass. N Engl J Med 362(7):624–634. https://doi.org/10.1056/NEJMcp0910041
doi: 10.1056/NEJMcp0910041 pubmed: 20164486
Campbell SC et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182(4):1271–1279. https://doi.org/10.1016/j.juro.2009.07.004
doi: 10.1016/j.juro.2009.07.004 pubmed: 19683266
Huang WC et al (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7(9):735–740. https://doi.org/10.1016/S1470-2045(06)70803-8
doi: 10.1016/S1470-2045(06)70803-8 pubmed: 16945768 pmcid: 2239298
Simone G, Ferriero M, Papalia R, Costantini M, Guaglianone S, Gallucci M (2013) Zero-ischemia minimally invasive partial nephrectomy. Curr Urol Rep 14(5):465–470. https://doi.org/10.1007/s11934-013-0359-0
doi: 10.1007/s11934-013-0359-0 pubmed: 23893291
Thompson RH et al (2012) Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 79(2):356–360. https://doi.org/10.1016/j.urology.2011.10.031
doi: 10.1016/j.urology.2011.10.031 pubmed: 22310752
Guillonneau B et al (2003) Laparoscopic partial nephrectomy for renal tumor: single center experience comparing clamping and no clamping techniques of the renal vasculature. J Urol 169(2):483–486. https://doi.org/10.1016/S0022-5347(05)63939-0
doi: 10.1016/S0022-5347(05)63939-0 pubmed: 12544293
Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182(3):844–853. https://doi.org/10.1016/j.juro.2009.05.035
doi: 10.1016/j.juro.2009.05.035 pubmed: 19616235
Zargar H et al (2015) The impact of extended warm ischemia time on late renal function after robotic partial nephrectomy. J Endourol 29(4):444–448. https://doi.org/10.1089/end.2014.0557
doi: 10.1089/end.2014.0557 pubmed: 25203268
Minervini A et al (2020) Impact of resection technique on perioperative outcomes and surgical margins after partial nephrectomy for localized renal masses: a prospective multicenter study. J Urol 203(3):496–504. https://doi.org/10.1097/JU.0000000000000591
doi: 10.1097/JU.0000000000000591 pubmed: 31609167
Volpe A et al (2015) Renal ischemia and function after partial nephrectomy: a collaborative review of the literature. Eur Urol 68(1):61–74. https://doi.org/10.1016/j.eururo.2015.01.025
doi: 10.1016/j.eururo.2015.01.025 pubmed: 25703575
Mohapatra A, Potretzke A, Weaver J, Anderson B, Vetter J, Figenshau R (2017) Trends in the management of small renal masses: a survey of members of the Endourological Society. J Kidney Cancer VHL 4(3):10. https://doi.org/10.15586/jkcvhl.2017.82
doi: 10.15586/jkcvhl.2017.82 pubmed: 28752023 pmcid: 5519769
Garisto J et al (2018) Robotic versus open partial nephrectomy for highly complex renal masses: Comparison of perioperative, functional, and oncological outcomes. Urol Oncol 36(10):471.e1-471.e9. https://doi.org/10.1016/j.urolonc.2018.06.012
doi: 10.1016/j.urolonc.2018.06.012 pubmed: 30100111
Thompson RH et al (2010) Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol 58(3):340–345. https://doi.org/10.1016/j.eururo.2010.05.047
doi: 10.1016/j.eururo.2010.05.047 pubmed: 20825756
Volpe A et al (2014) Perioperative and renal functional outcomes of elective robot-assisted partial nephrectomy (RAPN) for renal tumours with high surgical complexity: RAPN for renal tumours with high surgical complexity. BJU Int 114(6):903–909. https://doi.org/10.1111/bju.12751
doi: 10.1111/bju.12751 pubmed: 24673750
Gill IS et al (2011) ‘Zero ischemia’ partial nephrectomy: novel laparoscopic and robotic technique. Eur Urol 59(1):128–134. https://doi.org/10.1016/j.eururo.2010.10.002
doi: 10.1016/j.eururo.2010.10.002 pubmed: 20971550
Zhou L et al (2015) Selective versus hilar clamping during minimally invasive partial nephrectomy: a systematic review and meta-analysis. J Endourol 29(8):855–863. https://doi.org/10.1089/end.2014.0878
doi: 10.1089/end.2014.0878 pubmed: 25746718
Porpiglia F, Fiori C, Checcucci E, Amparore D, Bertolo R (2018) Hyperaccuracy three-dimensional reconstruction is able to maximize the efficacy of selective clamping during robot-assisted partial nephrectomy for complex renal masses. Eur Urol 74(5):651–660. https://doi.org/10.1016/j.eururo.2017.12.027
doi: 10.1016/j.eururo.2017.12.027 pubmed: 29317081
Rod X et al (2016) Impact of ischaemia time on renal function after partial nephrectomy: a systematic review. BJU Int 118(5):692–705. https://doi.org/10.1111/bju.13580
doi: 10.1111/bju.13580 pubmed: 27409986
Bertolo R et al (2019) Off-clamp vs on-clamp robotic partial nephrectomy: Perioperative, functional and oncological outcomes from a propensity-score matching between two high-volume centers. Eur J Surg Oncol 45(7):1232–1237. https://doi.org/10.1016/j.ejso.2018.12.005
doi: 10.1016/j.ejso.2018.12.005 pubmed: 30553632
Anderson BG et al (2019) Comparing off-clamp and on-clamp robot-assisted partial nephrectomy: a prospective randomized trial. Urology 126:102–109. https://doi.org/10.1016/j.urology.2018.11.053
doi: 10.1016/j.urology.2018.11.053 pubmed: 30659901
Bove P et al (2020) Deviation from the protocol of a randomized clinical trial comparing on-clamp versus off-clamp laparoscopic partial nephrectomy (CLOCK II laparoscopic study): a real-life analysis. J Urol. https://doi.org/10.1097/JU.0000000000001417
doi: 10.1097/JU.0000000000001417 pubmed: 33355504
T. A. G. (Italian G. for A. L.-E. Surgery) et al (2020) Safety of on- vs off-clamp robotic partial nephrectomy: per-protocol analysis from the data of the CLOCK randomized trial. World J Urol 38(5):1101–1108. https://doi.org/10.1007/s00345-019-02879-4
doi: 10.1007/s00345-019-02879-4
Antonelli A et al (2019) Predictors of the transition from off to on clamp approach during ongoing robotic partial nephrectomy: data from the CLOCK randomized clinical trial. J Urol 202(1):62–68. https://doi.org/10.1097/JU.0000000000000194
doi: 10.1097/JU.0000000000000194 pubmed: 30827166
Cacciamani GE et al (2019) Impact of renal hilar control on outcomes of robotic partial nephrectomy: systematic review and cumulative meta-analysis. Eur Urol Focus 5(4):619–635. https://doi.org/10.1016/j.euf.2018.01.012
doi: 10.1016/j.euf.2018.01.012 pubmed: 29422419
Larcher A et al (2019) The learning curve for robot-assisted partial nephrectomy: impact of surgical experience on perioperative outcomes. Eur Urol 75(2):253–256. https://doi.org/10.1016/j.eururo.2018.08.042
doi: 10.1016/j.eururo.2018.08.042 pubmed: 30243798
Peyronnet B et al (2018) Impact of hospital volume and surgeon volume on robot-assisted partial nephrectomy outcomes: a multicentre study. BJU Int 121(6):916–922. https://doi.org/10.1111/bju.14175
doi: 10.1111/bju.14175 pubmed: 29504226
Dagenais J et al (2019) Variability in partial nephrectomy outcomes: does your surgeon matter? Eur Urol 75(4):628–634. https://doi.org/10.1016/j.eururo.2018.10.046
doi: 10.1016/j.eururo.2018.10.046 pubmed: 30396636
Antonelli A et al (2019) On-clamp versus off-clamp robotic partial nephrectomy: a systematic review and meta-analysis. Urol J 86(2):52–62. https://doi.org/10.1177/0391560319847847
doi: 10.1177/0391560319847847

Auteurs

Adil Mellouki (A)

Department of Urology, Andrology and Renal Transplant, Pasteur II University Hospital, 30 Avenue Romaine, 06001, Nice, France.

Imad Bentellis (I)

Department of Urology, Andrology and Renal Transplant, Pasteur II University Hospital, 30 Avenue Romaine, 06001, Nice, France.

Arnoult Morrone (A)

Department of Urology, Andrology and Renal Transplant, Pasteur II University Hospital, 30 Avenue Romaine, 06001, Nice, France.

Nicolas Doumerc (N)

Department of Urology, University Hospital of Toulouse, Toulouse, France.

Jean-Baptiste Beauval (JB)

Department of Urology, University Hospital of Toulouse, Toulouse, France.

Morgane Roupret (M)

APHP Department of Urology, Bicetre University Hospital, Paris Saclay University, Le Kremlin Bicetre, France.

François-Xavier Nouhaud (FX)

Department of Urology, University Hospital of Rouen, Rouen, France.

Cedric Lebacle (C)

APHP Department of Urology, Bicetre University Hospital, Paris Saclay University, Le Kremlin Bicetre, France.

Jean-Alexandre Long (JA)

Department of Urology, University Hospital of Grenoble, Grenoble, France.

Daniel Chevallier (D)

Department of Urology, Andrology and Renal Transplant, Pasteur II University Hospital, 30 Avenue Romaine, 06001, Nice, France.

Brannwel Tibi (B)

Department of Urology, Andrology and Renal Transplant, Pasteur II University Hospital, 30 Avenue Romaine, 06001, Nice, France.

Aysha Shaikh (A)

Department of Urology, Andrology and Renal Transplant, Pasteur II University Hospital, 30 Avenue Romaine, 06001, Nice, France.

L Imbert de la Phalecque (L)

Department of Urology, Andrology and Renal Transplant, Pasteur II University Hospital, 30 Avenue Romaine, 06001, Nice, France.

Pierre Pillot (P)

Department of Urology, University Hospital of Poitiers, Poitiers, France.

Xavier Tillou (X)

Department of Urology, University Hospital of Caen, Caen, France.

Jean-Christophe Bernhard (JC)

Department of Urology, University Hospital of Bordeaux, Bordeaux, France.

Matthieu Durand (M)

Department of Urology, Andrology and Renal Transplant, Pasteur II University Hospital, 30 Avenue Romaine, 06001, Nice, France.

Youness Ahallal (Y)

Department of Urology, Andrology and Renal Transplant, Pasteur II University Hospital, 30 Avenue Romaine, 06001, Nice, France. ahallal.y@chu-nice.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH